Cardiovascular considerations of attention deficit hyperactivity disorder medications: a report of the European Network on Hyperactivity Disorders work group, European Attention Deficit Hyperactivity Disorder Guidelines Group on attention deficit hyperactivity disorder drug safety meeting

Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD Agents

(2011) H. Schelleman et al.   PEDIATRICS

Modeled Economic Evaluation of Alternative Strategies to Reduce Sudden Cardiac Death Among Children Treated for Attention Deficit/Hyperactivity Disorder

(2010) Peter Denchev et al.   CIRCULATION

Sudden Death and Use of Stimulant Medications in Youths

(2009) Madelyn S. Gould et al.   AMERICAN JOURNAL OF PSYCHIATRY

Stimulant Use Linked to Sudden Death in Children Without Heart Problems

(2009) Bridget M. Kuehn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

(2009) Thomas J. Spencer et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension

(2009) Empar Lurbe et al.   JOURNAL OF HYPERTENSION

Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder

(2008) Victoria L. Vetter et al.   CIRCULATION

American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD

(2008) &NA;   JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS

Inattention, Hyperactivity, and School Performance in a Population of School-Age Children With Complex Congenital Heart Disease

(2008) A. J. Shillingford et al.   PEDIATRICS